We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Reassessing pretest probability: Coronary artery calcium alone predicts obstructive CAD
Since the 1970s, patient selection for cardiac stress testing—using electrocardiographic, nuclear, and echocardiographic modalities—has relied on estimating the pretest likelihood of obstructive coronary artery disease (oCAD). In recent years, several algorithms have integrated coronary artery calcium (CAC) scores into predictive models for assessing oCAD risk. However, even the simplest of these models combine CAC with other variables such as age, sex, and clinical symptoms.1
-
Multicenter Study Finds Abbreviated MRI Non-Inferior to mpMRI for csPCa Detection
Abbreviated biparametric MRI demonstrated nearly equivalent detection rates for clinically significant and clinically insignificant prostate cacner as multiparametric MRI, according to research involving 22 centers in 12 countries.
-
FDA Clears Updated AI Software for Generating Inline Mapping with Cardiac MRI
The AI-powered Tempus Pixel software update provides T1 and T2 inline maps to augment cardiac MRI assessment.
-
Study Links Calcium Crystals to Future Knee OA
Knee calcium crystal deposition may drive osteoarthritis development, pointing to possible interventions for high-risk patients. Medscape Medical News
-
Contrast-Free MRI Could Become Standard for Prostate Cancer Diagnosis, Study Says
(MedPage Today) — Abbreviated biparametric MRI was noninferior to full multiparametric MRI in detecting clinically significant prostate cancer in the prospective PRIME study, suggesting that it could become the new standard of care.
Among 490… -
FDA Grants 510(k) Clearance to OsteoSight
tim.hodson
Thu, 09/11/2025 – 11:35
Sept. 11, 2025 — Naitive Technologies, a medical technology company developing AI-driven software to reimagine orthopedic care, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its flagship product, OsteoSight. OsteoSight enables opportunistic assessment of bone mineral density (BMD) using standard X-rays acquired to investigate other clinical concerns, such as pain associated with arthritis …
-
Philips Plans to Expand Scanner Offerings
tim.hodson
Thu, 09/11/2025 – 09:44
Sept. 8, 2025 — Pathology plays a crucial role in the diagnosis of a variety of diseases, particularly cancer, through examination of patient tissue samples. With an estimated 70% of important medical decisions involving laboratory or pathology tests2, the availability of digitally stored pathology images is especially important as it has a significant impact on patient care. The digital transformation of pathology also means there is a growing ne…
-
Updated Molecular Imaging Software with Centiloid Scale Quantification Gets FDA Nod
The latest edition of the Hermia software reportedly facilitates standard evaluation of amyloid PET quantification across a variety of tracers and protocols.
-
Medicare pays about half of radiology SaaS AI claims
Between 2018 and 2023, radiologists received $8 million in payments but were denied a potential $16.4 million.